Starling Oncology, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $508.0K | $-686.0K | $1.2M | $151.0K |
| FY2021 | $-32.7M | $-35.5M | $2.8M | $24.5M |
| FY2022 | $-61.8M | $-67.3M | $5.5M | $27.7M |
| FY2023 | $-36.3M | $-40.9M | $4.6M | $17.8M |
| FY2024 | $-26.5M | $-30.3M | $3.8M | $11.2M |
| FY2025 | $-24.6M | $-27.8M | $3.2M | $4.6M |